4-Amino-1-[3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-ribofuranosyl]-1,3,5-triazin-2(1H)-one manufacturers
|
| | 4-Amino-1-[3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-ribofuranosyl]-1,3,5-triazin-2(1H)-one Basic information |
| Product Name: | 4-Amino-1-[3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-ribofuranosyl]-1,3,5-triazin-2(1H)-one | | Synonyms: | 4-Amino-1-[3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-ribofuranosyl]-1,3,5-triazin-2(1H)-one;4-Amino-1-[3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-
disiloxanediyl]-beta-D-ribofuranosyl]-1,3,5-triazin-2(1H)-one;1,3,5-Triazin-2(1H)-one, 4-amino-1-[3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-ribofuranosyl]-;-Amino-1-[3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-beta-D-ribofuranosyl]-1,3,5-triazin-2(1H)-one | | CAS: | 676607-90-2 | | MF: | C20H38N4O6Si2 | | MW: | 486.72 | | EINECS: | | | Product Categories: | | | Mol File: | 676607-90-2.mol | ![4-Amino-1-[3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-ribofuranosyl]-1,3,5-triazin-2(1H)-one Structure](CAS/20211123/GIF/676607-90-2.gif) |
| | 4-Amino-1-[3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-ribofuranosyl]-1,3,5-triazin-2(1H)-one Chemical Properties |
| Boiling point | 509.5±60.0 °C(Predicted) | | density | 1.28±0.1 g/cm3(Predicted) | | solubility | DMF, DMSO, Methanol | | form | Solids | | pka | 13.16±0.40(Predicted) | | color | White |
| | 4-Amino-1-[3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-ribofuranosyl]-1,3,5-triazin-2(1H)-one Usage And Synthesis |
| Uses | 4-Amino-1-[3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-ribofuranosyl]-1,3,5-triazin-2(1H)-one is an intermediate in the synthesis of metabolites of Azadeoxycytidine (A796950), as neoplasm inhibitor. |
| | 4-Amino-1-[3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-ribofuranosyl]-1,3,5-triazin-2(1H)-one Preparation Products And Raw materials |
|